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Despite advances in prevention, diag-
nosis and treatment of tuberculosis and 
human immunodeficiency virus (HIV), 
tuberculosis remains the leading cause 
of death and illness among people liv-
ing with HIV. In 2015, an estimated 1.2 
million of the people who developed 
tuberculosis disease worldwide were 
HIV positive, and tuberculosis was the 
direct cause of at least one third of HIV-
related deaths.1 The 2015 “Treat All” 
strategy requires that everyone with HIV 
is offered antiretroviral therapy (ART) 
as soon as they are diagnosed. By treat-
ing HIV infections earlier, this strategy 
should mitigate the HIV-associated 
tuberculosis epidemic, but it alone is 
not sufficient to eliminate preventable 
tuberculosis suffering and deaths among 
people living with HIV.2 The 2016 World 
Health Organization (WHO) guidelines 
recommend differentiated HIV service 
delivery, which is intended to facilitate 
the “Treat All” strategy by tailoring 
services to the differing needs of indi-
viduals.3 As HIV programmes adopt 
these WHO guidelines, tuberculosis also 
needs to be addressed.3
Compared to the general popula-
tion, people living with HIV have a 
significantly higher risk of tuberculosis 
even if they are stable on treatment and 
have high CD4+ T-lymphocyte counts.4 
Therefore, WHO recommends that all 
people living with HIV are screened 
for tuberculosis symptoms (cough of 
any duration, weight loss, fever or night 
sweats) at every patient encounter.3 One 
of the implications of differentiated care 
is that the intervals between clinic visits 
and/or antiretroviral pick-ups from 
pharmacies may be extended to three 
or six months for people who are stable 
on ART. However, routine tuberculosis 
screening is still needed regularly, fol-
lowed by appropriate evaluation, accu-
rate diagnosis and treatment for either 
tuberculosis disease or latent infection.3 
Patients should also be able to receive 
tuberculosis preventive therapy at the 
same time that they pick-up their anti-
retroviral medications.5–7
As part of differentiated care, com-
munity health workers, ART clubs and 
other models of community service 
delivery are increasingly being used by 
HIV-treatment programmes. In these 
models, participants could be trained 
to screen for symptoms of tuberculosis 
and other opportunistic infections, refer 
people for further evaluation and dis-
pense tuberculosis preventive therapy. 
This approach has been piloted in sev-
eral sub-Saharan African settings.8–12 
In addition, improving participants’ 
understanding of tuberculosis will help 
them to recognize symptoms in them-
selves and family members and advocate 
for their own care. Active tuberculosis 
case-finding among household mem-
bers and close contacts of tuberculosis 
patients is critical to finding an estimated 
4.3 million people with undiagnosed 
tuberculosis.1 More collaboration with 
national tuberculosis programmes is 
needed to support or expand commu-
nity- or household-level tuberculosis 
case-finding activities, such as sputum 
collection and transport, directly ob-
served therapy, monitoring for adverse 
events, tracing of people not completing 
treatment, as well as nutritional support, 
and health education.8–12 Collaboration 
with civil society organizations will also 
be needed to understand – and adapt ser-
vice delivery to – local context and needs.
Differentiated care is also expected 
to make more facility-based resources 
available to care for patients with ad-
vanced and/or unstable disease. For 
these patients, in addition to the early 
antiretroviral treatment they should 
already be receiving, tuberculosis pre-
vention, targeted case-finding and diag-
nosis are urgently needed. In addition to 
symptom-screening and rapid diagnos-
tic tests for HIV-associated tuberculosis, 
supplemental urine lipoarabinomannan 
testing can be used to diagnose dissemi-
nated tuberculosis in the sickest people 
living with HIV, who are at greatest risk 
of death.3 As stable patients are managed 
more in communities, and facilities 
increasingly become service delivery 
points for patients with advanced dis-
ease, strong infection prevention and 
control measures are required to prevent 
iatrogenic transmission of tuberculosis.
Integrating tuberculosis and HIV 
activities will allow more people to 
benefit from the lifesaving potential of 
the “Treat All” strategy. Differentiated 
care-delivery systems that account for 
both tuberculosis and HIV could im-
prove access to services, use existing 
human resources and supply chains 
more efficiently and strengthen moni-
toring and evaluation efforts for both 
diseases. ■
Addressing tuberculosis in differentiated care provision for people 
living with HIV
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